期刊
CLINICAL PHARMACOLOGY & THERAPEUTICS
卷 86, 期 1, 页码 109-113出版社
WILEY
DOI: 10.1038/clpt.2009.39
关键词
-
资金
- NIH [U01GM61373]
The development of robust and clinically valuable pharmacogenomic tests has been anticipated to be one of the first tangible results of the Human Genome Project. Despite both obvious and unanticipated obstacles, a number of tests have now become available in various practice settings. Lessons can be learned from examination of these tests, the evidence that has catalyzed their use, their value to prescribers, and their merit as tools for personalizing therapeutics.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据